Pre-analytical and analytical issues in the analysis of blood microparticles
暂无分享,去创建一个
[1] T G van Leeuwen,et al. Optical and non‐optical methods for detection and characterization of microparticles and exosomes , 2010, Journal of thrombosis and haemostasis : JTH.
[2] E. Di Angelantonio,et al. Circulating procoagulant microparticles in acute pulmonary embolism: a case-control study. , 2010, International journal of cardiology.
[3] R. Bertina,et al. Plasma levels of microparticle-associated tissue factor activity in patients with clinically suspected pulmonary embolism. , 2010, Thrombosis research.
[4] A. Enjeti,et al. Circulating microparticles are elevated in carriers of factor V Leiden. , 2010, Thrombosis research.
[5] N. Mackman,et al. Increased microparticle tissue factor activity in cancer patients with Venous Thromboembolism. , 2010, Thrombosis research.
[6] M. Zembala,et al. Circulating tumour-derived microvesicles in plasma of gastric cancer patients , 2010, Cancer Immunology, Immunotherapy.
[7] D. Connor,et al. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib , 2010, Thrombosis and Haemostasis.
[8] A. Kakkar,et al. Cancer-associated thrombosis , 2010, British Journal of Cancer.
[9] R. Nieuwland,et al. Why do cells release vesicles? , 2010, Thrombosis research.
[10] J. Zwicker. Predictive value of tissue factor bearing microparticles in cancer associated thrombosis. , 2010, Thrombosis research.
[11] C. Vrints,et al. Flow cytometric detection of endothelial microparticles (EMP): effects of centrifugation and storage alter with the phenotype studied. , 2010, Thrombosis research.
[12] Vasco Filipe,et al. Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein Aggregates , 2010, Pharmaceutical Research.
[13] Fariborz Mobarrez,et al. A multicolor flow cytometric assay for measurement of platelet-derived microparticles. , 2010, Thrombosis research.
[14] T H Oosterkamp,et al. Atomic force microscopy: a novel approach to the detection of nanosized blood microparticles , 2010, Journal of thrombosis and haemostasis : JTH.
[15] M. Lederman,et al. Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation. , 2010, Blood.
[16] D. Neuberg,et al. Tumor-Derived Tissue FactorBearing Microparticles Are Associated With Venous Thromboembolic Events in Malignancy , 2009, Clinical Cancer Research.
[17] D. Connor,et al. Detection of the procoagulant activity of microparticle-associated phosphatidylserine using XACT , 2009, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[18] R. Bertina,et al. Microparticle‐associated tissue factor activity in cancer patients with and without thrombosis , 2009, Journal of thrombosis and haemostasis : JTH.
[19] C. Théry,et al. Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.
[20] A. Kastrati,et al. Plasma TF activity predicts cardiovascular mortality in patients with acute myocardial infarction , 2009, Thrombosis journal.
[21] G. Cimmino,et al. Assessment of plasma tissue factor activity in patients presenting with coronary artery disease: limitations of a commercial assay , 2009, Journal of thrombosis and haemostasis : JTH.
[22] R. Cardigan,et al. Microparticle sizing by dynamic light scattering in fresh‐frozen plasma , 2009, Vox sanguinis.
[23] P. Fontana,et al. Cell-derived microparticles in haemostasis and vascular medicine , 2009, Thrombosis and Haemostasis.
[24] J. Freyssinet,et al. Circulating procoagulant microparticles in patients with venous thromboembolism. , 2009, Thrombosis research.
[25] H. Verheul,et al. Proteomics of the TRAP-induced platelet releasate. , 2009, Journal of proteomics.
[26] Jacopo Meldolesi,et al. Shedding microvesicles: artefacts no more. , 2009, Trends in cell biology.
[27] A. Falus,et al. Highlights of a new type of intercellular communication: microvesicle-based information transfer , 2009, Inflammation Research.
[28] A. Ganser,et al. Recovery and composition of microparticles after snap-freezing depends on thawing temperature , 2009, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[29] L. Arnaud,et al. Standardization of platelet‐derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies? , 2009, Journal of thrombosis and haemostasis : JTH.
[30] J. Hudson,et al. Platelet microparticle-associated protein disulfide isomerase promotes platelet aggregation and inactivates insulin. , 2008, Biochimica et biophysica acta.
[31] J. Hartwig,et al. Differential stimulation of monocytic cells results in distinct populations of microparticles , 2008, Journal of thrombosis and haemostasis : JTH.
[32] R. Nieuwland,et al. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease , 2008, Haematologica.
[33] A. Khorana,et al. Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer , 2008, Journal of thrombosis and haemostasis : JTH.
[34] Thomas Behrenbeck,et al. Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women. , 2008, American journal of physiology. Heart and circulatory physiology.
[35] T. Nakayama,et al. Level, distribution and correlates of platelet-derived microparticles in healthy individuals with special reference to the metabolic syndrome , 2008, Thrombosis and Haemostasis.
[36] J. Freyssinet,et al. Elevated levels of circulating procoagulant microparticles in patients with β-thalassemia intermedia , 2008, Haematologica.
[37] A. Enjeti,et al. Bio‐maleimide as a generic stain for detection and quantitation of microparticles , 2008, International journal of laboratory hematology.
[38] Fraser K. McNeil-Watson,et al. Measuring sub nanometre sizes using dynamic light scattering , 2008 .
[39] A. Guha,et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells , 2008, Nature Cell Biology.
[40] Nigel Mackman,et al. Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. , 2008, The Journal of clinical investigation.
[41] S. Coughlin,et al. A critical role for extracellular protein disulfide isomerase during thrombus formation in mice. , 2008, The Journal of clinical investigation.
[42] I. Sargent,et al. Circulating microparticles in normal pregnancy and pre-eclampsia. , 2008, Placenta.
[43] Mona D. Shah,et al. Flow cytometric measurement of microparticles: Pitfalls and protocol modifications , 2008, Platelets.
[44] Jean-Luc Pellequer,et al. Past, present and future of atomic force microscopy in life sciences and medicine , 2007, Journal of molecular recognition : JMR.
[45] A. Enjeti,et al. Detection and Measurement of Microparticles: An Evolving Research Tool for Vascular Biology , 2007, Seminars in thrombosis and hemostasis.
[46] R. Nieuwland,et al. Microparticles and Exosomes: Impact on Normal and Complicated Pregnancy , 2007, American journal of reproductive immunology.
[47] H. Versteeg,et al. Tissue Factor Coagulant Function Is Enhanced by Protein-disulfide Isomerase Independent of Oxidoreductase Activity* , 2007, Journal of Biological Chemistry.
[48] J. Clifton,et al. Mammalian plasma membrane proteomics , 2007, Proteomics.
[49] A. Piccin,et al. Circulating microparticles: pathophysiology and clinical implications. , 2007, Blood reviews.
[50] N. Key,et al. Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: Studies using a new digital flow cytometer , 2007, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[51] S. Eichinger,et al. Tissue factor-positive microparticles: Cellular origin and association with coagulation activation in patients with colorectal cancer , 2006, Thrombosis and Haemostasis.
[52] A. Nagler,et al. Functional CXCR4-expressing microparticles and SDF-1 correlate with circulating acute myelogenous leukemia cells. , 2006, Cancer Research.
[53] K. Ley,et al. Proteomic discovery of 21 proteins expressed in human plasma-derived but not platelet-derived microparticles , 2006, Thrombosis and Haemostasis.
[54] G. Lippi,et al. Venous stasis and routine hematologic testing. , 2006, Clinical and laboratory haematology.
[55] G. Lippi,et al. Quality and reliability of routine coagulation testing: can we trust that sample? , 2006, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[56] R. Bertina,et al. Microparticle‐associated tissue factor activity: a link between cancer and thrombosis? , 2007, Journal of thrombosis and haemostasis : JTH.
[57] R. D. de Winter,et al. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction. , 2006, Clinical chemistry.
[58] M. Haubitz,et al. Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocol , 2006, Journal of thrombosis and haemostasis : JTH.
[59] J. Freyssinet,et al. Phosphatidylserine and Signal Transduction: Who Needs Whom? , 2006, Science's STKE.
[60] E. Kretzschmar,et al. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease , 2006, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[61] C. Sáez,et al. Circulating platelet-derived microparticles in systemic lupus erythematosus , 2005, Thrombosis and Haemostasis.
[62] G. Dale,et al. Quantitation of microparticles released from coated‐platelets , 2005, Journal of thrombosis and haemostasis : JTH.
[63] B. Østerud,et al. Generation of Tissue factor-rich microparticles in an ex vivo whole blood model , 2005, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[64] Klaus Ley,et al. The platelet microparticle proteome. , 2005, Journal of proteome research.
[65] C. Palii,et al. Novel fluorescence assay using calcein‐AM for the determination of human erythrocyte viability and aging , 2005, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[66] P. Comfurius,et al. Surface exposure of phosphatidylserine in pathological cells , 2005, Cellular and Molecular Life Sciences CMLS.
[67] Y. Ahn. Cell‐derived microparticles: ‘Miniature envoys with many faces’ , 2005, Journal of thrombosis and haemostasis : JTH.
[68] A. Mulder,et al. Preanalytical variables and off-site blood collection: influences on the results of the prothrombin time/international normalized ratio test and implications for monitoring of oral anticoagulant therapy. , 2005, Clinical chemistry.
[69] L. Horstman,et al. New horizons in the analysis of circulating cell-derived microparticles. , 2004, The Keio journal of medicine.
[70] C. W. Heegaard,et al. Lactadherin binds selectively to membranes containing phosphatidyl-L-serine and increased curvature. , 2004, Biochimica et biophysica acta.
[71] E. Favaloro,et al. Potential laboratory misdiagnosis of hemophilia and von Willebrand disorder owing to cold activation of blood samples for testing. , 2004, American journal of clinical pathology.
[72] R. Nieuwland,et al. Measuring circulating cell‐derived microparticles , 2004, Journal of thrombosis and haemostasis : JTH.
[73] G. Escolar,et al. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. , 2004, Blood.
[74] L. Hefler,et al. To butterfly or to needle: the pilot phase. , 2004, Annals of internal medicine.
[75] A. Grant,et al. Assessment of platelet activation in several different anticoagulants by the Advia 120 Hematology System, fluorescence flow cytometry, and electron microscopy , 2003, Thrombosis and Haemostasis.
[76] R. Hebbel,et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. , 2003, Blood.
[77] J. Chou,et al. Accumulation of Tissue Factor into Developing Thrombi In Vivo Is Dependent upon Microparticle P-Selectin Glycoprotein Ligand 1 and Platelet P-Selectin , 2003, The Journal of experimental medicine.
[78] J. Yates,et al. A method for the comprehensive proteomic analysis of membrane proteins , 2003, Nature Biotechnology.
[79] L. Horstman,et al. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. , 2003, Thrombosis research.
[80] Patrice Darmon,et al. Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. , 2002, Diabetes.
[81] Y. J. Lee,et al. Optimized flow cytometric assay for the measurement of platelet microparticles in plasma: pre-analytic and analytic considerations , 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[82] M. Macey,et al. Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology system. , 2002, Clinical chemistry.
[83] Veronica Huber,et al. Induction of Lymphocyte Apoptosis by Tumor Cell Secretion of FasL-bearing Microvesicles , 2002, The Journal of experimental medicine.
[84] R. Salomão,et al. Influence of EDTA and heparin on lipopolysaccharide binding and cell activation, evaluated at single-cell level in whole blood. , 2002, Cytometry.
[85] B. Polack,et al. Preanalytical Recommendations of the ‘Groupe d’Etude sur l’Hémostase et la Thrombose’ (GEHT) for Venous Blood Testing in Hemostasis Laboratories , 2001, Pathophysiology of Haemostasis and Thrombosis.
[86] C. Hack,et al. Cell-derived Microparticles Circulate in Healthy Humans and Support Low Grade Thrombin Generation , 2001, Thrombosis and Haemostasis.
[87] R. Junker,et al. Citrate-theophylline-adenine-dipyridamol buffer is preferable to citrate buffer as an anticoagulant for flow cytometric measurement of platelet activation. , 1999, Clinical chemistry.
[88] I. Wang,et al. Platelet-derived microparticles on synthetic surfaces observed by atomic force microscopy and fluorescence microscopy. , 1999, Biomaterials.
[89] A. Engel,et al. Adsorption of biological molecules to a solid support for scanning probe microscopy. , 1997, Journal of structural biology.
[90] J. Freyssinet,et al. The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection. , 1997, The Journal of clinical investigation.
[91] D. Gibson,et al. Phospholipid binding of annexin V: effects of calcium and membrane phosphatidylserine content. , 1992, Archives of biochemistry and biophysics.
[92] F. Ackerman,et al. The significance of a wish. , 1991, The Hastings Center report.
[93] G. Contant,et al. Heparin inactivation during blood storage: its prevention by blood collection in citric acid, theophylline, adenosine, dipyridamole-C.T.A.D. mixture. , 1983, Thrombosis research.
[94] R. Hoffman,et al. Flow cytometric electronic direct current volume and radiofrequency impedance measurements of single cells and particles. , 1981, Cytometry.
[95] P. Wolf. The Nature and Significance of Platelet Products in Human Plasma , 1967, British journal of haematology.
[96] J. Freyssinet,et al. Pathophysiologic significance of procoagulant microvesicles in cancer disease and progression , 2009, Hämostaseologie.
[97] Y. Ikeda,et al. Assessment of an ELISA kit for platelet-derived microparticles by joint research at many institutes in Japan. , 2009, Journal of atherosclerosis and thrombosis.
[98] M. Gelderman,et al. Flow cytometric analysis of cell membrane microparticles. , 2008, Methods in molecular biology.
[99] F. George. Microparticles in vascular diseases. , 2008, Thrombosis research.
[100] Y. Ikeda,et al. Function and role of microparticles in various clinical settings. , 2008, Thrombosis research.
[101] K. Ley,et al. Plasma-derived microparticles for biomarker discovery. , 2008, Clinical laboratory.
[102] J. Nieva,et al. Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients. , 2008, Thrombosis research.
[103] J. Harris,et al. Negative staining of thinly spread biological samples. , 2007, Methods in molecular biology.
[104] L. Miguet,et al. Microparticles: a new tool for plasma membrane sub-cellular proteomic. , 2007, Sub-cellular biochemistry.
[105] L. Azevedo,et al. Circulating microparticles as therapeutic targets in cardiovascular diseases. , 2007, Recent patents on cardiovascular drug discovery.
[106] A. Minagar,et al. Cell-derived microparticles and exosomes in neuroinflammatory disorders. , 2007, International review of neurobiology.
[107] Miguel Ángel Martínez,et al. Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization , 2006, Proteomics.
[108] A. Nagler,et al. Functional CXCR 4-Expressing Microparticles and SDF-1 Correlate with Circulating Acute Myelogenous Leukemia Cells , 2006 .
[109] J J Sixma,et al. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. , 1999, Blood.
[110] L. G. Davis,et al. Basic methods in molecular biology , 1986 .